Breaking News Instant updates and real-time market news.

DE

Deere

$149.20

5.49 (3.82%)

07:23
08/19/19
08/19
07:23
08/19/19
07:23

Deere price target lowered to $170 from $185 at Wells Fargo

Wells Fargo analyst Andrew Casey lowered his price target for Deere to $170 from $185 mainly on reduced valuation multiples due to recent USDA data that imply a less robust outlook for U.S. farmer row crop cash receipts. The analyst notes that the stock took the Q3 earnings miss and guidance cut in stride. He reiterates an Outperform rating on the shares.

  • 27

    Nov

DE Deere
$149.20

5.49 (3.82%)

08/14/19
DBAB
08/14/19
NO CHANGE
Target $155
DBAB
Hold
Deere price target lowered to $155 from $163 at Deutsche Bank
Deutsche Bank analyst Chad Dillard lowered his price target for Deere to $155 from $163 saying the "disappointing" WASDE report on Monday "fundamentally altered" the setup into the company's fiscal Q3 earnings on Friday. The tone from management is likely to be cautious, which may drive a downward revision in 2020 consensus numbers, Dillard tells investors in a pre-earnings research note. He keeps a Hold rating on Deere.
08/14/19
SPHN
08/14/19
INITIATION
Target $160
SPHN
Equal Weight
Deere initiated with an Equal Weight at Stephens
Stephens analyst Ashish Gupta started Deere with an Equal Weight rating and $160 price target.
08/14/19
SPHN
08/14/19
INITIATION
Target $160
SPHN
Equal Weight
Deere initiated with an Equal Weight at Stephens
Stephens analyst Ashish Gupta initiated Deere with an Equal Weight rating and a price target of $160. The analyst notes that the findings of the latest WASDE report suggests that this year's corn crop will be larger and prices will trend down. Gupta expects Deere shares to be volatile as the market digests crop updates, but expects to look for entry opportunities as "shares adjust to the reduced outlook for U.S. farmers."
08/15/19
08/15/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Slack Technologies (WORK) initiated with a Market Perform at Bernstein. 2. Agco (AGCO) initiated with an Overweight at Stephens, while Deere (DE) initiated with an Equal Weight, and Caterpillar (CAT) was initiated with an Underweight. 3. QuickLogic (QUIK) initiated with an Outperform at Oppenheimer. 4. ABM (ABM) initiated with a Market Perform at William Blair. 5. Charter (CHTR) initiated with a Hold at Benchmark. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

MCFT

MasterCraft Boat Holdings

$14.41

-0.1 (-0.69%)

06:55
09/17/19
09/17
06:55
09/17/19
06:55
Conference/Events
MasterCraft Boat Holdings to host investor day »

Investor day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Sep

OSMT

Osmotica Pharmaceuticals

$3.84

0.15 (4.07%)

06:51
09/17/19
09/17
06:51
09/17/19
06:51
Hot Stocks
Osmotica subsidiary submits NDA to FDA for RVL-1201 »

Vertical Pharmaceuticals,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EAST

Eastside Distilling

$4.97

-0.03 (-0.60%)

06:51
09/17/19
09/17
06:51
09/17/19
06:51
Conference/Events
Eastside Distilling to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Sep

ADS

Alliance Data

$132.88

-1.11 (-0.83%)

, SBH

Sally Beauty

$14.47

-0.12 (-0.82%)

06:49
09/17/19
09/17
06:49
09/17/19
06:49
Hot Stocks
Alliance Data signs agreement to provide credit card services for Sally Beauty »

Alliance Data (ADS) has…

ADS

Alliance Data

$132.88

-1.11 (-0.83%)

SBH

Sally Beauty

$14.47

-0.12 (-0.82%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Sep

  • 18

    Sep

  • 23

    Sep

  • 13

    Nov

  • 03

    Dec

KAMN

Kaman

$63.22

0.55 (0.88%)

06:49
09/17/19
09/17
06:49
09/17/19
06:49
Hot Stocks
Kaman awarded $42M order of Joint Programmable Fuzes »

Kaman announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZYME

Zymeworks

$25.84

0.19 (0.74%)

06:49
09/17/19
09/17
06:49
09/17/19
06:49
Hot Stocks
Zymeworks names Lota Zoth as board Chair, voluntarily delists from TSX »

Zymeworks announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

SBH

Sally Beauty

$14.47

-0.12 (-0.82%)

, ADS

Alliance Data

$132.88

-1.11 (-0.83%)

06:47
09/17/19
09/17
06:47
09/17/19
06:47
Hot Stocks
Sally Beauty signs agreement with Alliance Data's card services business »

Sally Beauty Holdings…

SBH

Sally Beauty

$14.47

-0.12 (-0.82%)

ADS

Alliance Data

$132.88

-1.11 (-0.83%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Sep

  • 18

    Sep

  • 23

    Sep

  • 13

    Nov

  • 03

    Dec

MRK

Merck

$82.01

-0.6 (-0.73%)

06:47
09/17/19
09/17
06:47
09/17/19
06:47
Hot Stocks
Merck: FDA accepts BLA, grants priority review for investigational Ebola vaccine »

Merck announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Sep

  • 20

    Sep

  • 24

    Sep

  • 27

    Sep

  • 02

    Oct

  • 03

    Oct

  • 29

    Oct

XLRN

Acceleron

$44.67

0.75 (1.71%)

06:43
09/17/19
09/17
06:43
09/17/19
06:43
Recommendations
Acceleron analyst commentary  »

Acceleron should be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 17

    Oct

  • 04

    Dec

  • 04

    Apr

CBMG

Cellular Biomedicine

$14.75

-0.16 (-1.07%)

06:43
09/17/19
09/17
06:43
09/17/19
06:43
Initiation
Cellular Biomedicine initiated  »

Cellular Biomedicine…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EGOV

NIC Inc.

$21.79

0.05 (0.23%)

06:40
09/17/19
09/17
06:40
09/17/19
06:40
Downgrade
NIC Inc. rating change  »

NIC Inc. downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

SPLK

Splunk

$114.87

1.19 (1.05%)

06:39
09/17/19
09/17
06:39
09/17/19
06:39
Upgrade
JPMorgan upgrades Splunk to Overweight after 19% selloff since late July »

JPMorgan analyst Mark…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

OLN

Olin

$19.27

0.46 (2.45%)

06:38
09/17/19
09/17
06:38
09/17/19
06:38
Conference/Events
Olin management to meet with SunTrust »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

  • 19

    Sep

  • 23

    Sep

CBMG

Cellular Biomedicine

$14.75

-0.16 (-1.07%)

06:38
09/17/19
09/17
06:38
09/17/19
06:38
Initiation
Cellular Biomedicine initiated  »

Cellular Biomedicine…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AXNX

Axonics

$30.13

-0.77 (-2.49%)

06:37
09/17/19
09/17
06:37
09/17/19
06:37
Initiation
Axonics initiated  »

Axonics initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HXGBY

Hexagon AB

$0.00

(0.00%)

06:36
09/17/19
09/17
06:36
09/17/19
06:36
Conference/Events
Hexagon AB management to meet with RBC Capital »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

  • 19

    Sep

APOG

Apogee Enterprises

$41.18

-0.38 (-0.91%)

06:34
09/17/19
09/17
06:34
09/17/19
06:34
Earnings
Apogee Enterprises reaffirms FY20 EPS view $3.00-$3.20, consensus $3.05 »

Reaffirms FY20 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Sep

  • 18

    Sep

  • 23

    Sep

MDGL

Madrigal Pharmaceuticals

$99.50

4.89 (5.17%)

06:34
09/17/19
09/17
06:34
09/17/19
06:34
Recommendations
Madrigal Pharmaceuticals analyst commentary  »

Madrigal Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SFTBF

SoftBank

$0.00

(0.00%)

, UBER

Uber

$34.42

1.18 (3.55%)

06:32
09/17/19
09/17
06:32
09/17/19
06:32
Periodicals
SoftBank backers consider slashing committments to Vision Fund, Bloomberg says »

The biggest backers of…

SFTBF

SoftBank

$0.00

(0.00%)

UBER

Uber

$34.42

1.18 (3.55%)

WE

We Company

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SSI

Stage Stores

$0.85

0.0298 (3.63%)

06:32
09/17/19
09/17
06:32
09/17/19
06:32
Hot Stocks
Stage Stores announces plans to convert substantially all stores to off-price »

Stage Stores announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APOG

Apogee Enterprises

$41.18

-0.38 (-0.91%)

06:31
09/17/19
09/17
06:31
09/17/19
06:31
Earnings
Apogee Enterprises reports Q2 EPS 72, consensus 64c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Sep

  • 18

    Sep

  • 23

    Sep

IAC

IAC

$229.23

1.71 (0.75%)

06:30
09/17/19
09/17
06:30
09/17/19
06:30
Initiation
IAC initiated  »

IAC initiated with a Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Oct

AMRN

Amarin

$17.26

0.55 (3.29%)

, MDCO

The Medicines Co.

$48.74

0.99 (2.07%)

06:29
09/17/19
09/17
06:29
09/17/19
06:29
Recommendations
Citi puts Amarin and Sarepta on top five SMid cap biotech pick list »

Citi analyst Joel Beatty…

AMRN

Amarin

$17.26

0.55 (3.29%)

MDCO

The Medicines Co.

$48.74

0.99 (2.07%)

NERV

Minerva

$8.12

0.12 (1.50%)

SRPT

Sarepta

$87.02

1.01 (1.17%)

ELOX

Eloxx Pharmaceuticals

$6.45

0.1 (1.57%)

NGM

NGM Biopharmaceuticals

$15.85

-0.15 (-0.94%)

PTCT

PTC Therapeutics

$42.99

0.16 (0.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

MRVL

Marvell

$25.39

-0.46 (-1.78%)

06:28
09/17/19
09/17
06:28
09/17/19
06:28
Hot Stocks
SEC says Marvell Technology to pay $5.5M to settle disclosure-related charges »

The Securities and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ANGI

Angi Homeservices

$7.91

-0.075 (-0.94%)

, GOOG

Alphabet

$1,231.36

-8.24 (-0.66%)

06:28
09/17/19
09/17
06:28
09/17/19
06:28
Initiation
Angi Homeservices, Alphabet, Alphabet Class A initiated  »

Angi Homeservices…

ANGI

Angi Homeservices

$7.91

-0.075 (-0.94%)

GOOG

Alphabet

$1,231.36

-8.24 (-0.66%)

GOOGL

Alphabet Class A

$1,231.45

-8.68 (-0.70%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 27

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.